Potential biomarkers predicting risk of pulmonary hypertension in congenital heart disease: The role of homocysteine and hydrogen sulfide

Chinese Medical Journal

Volumn 127, Issue 5, 2014, Pages 893-899

  Sun, Ling ^a,b   Sun, Shuo ^b   Li, Yu Fen ^b   Pan, Wei ^b   Xie, Yumei ^b   Wang, Shu Shui ^b   Zhang, Zhi Wei ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Biomarkers; Children; Congenital heart disease; Homocysteine; Hydrogen sulfide; Pulmonary hypertension

Indexed keywords

5, 10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; FOLIC ACID; HOMOCYSTEINE; HYDROGEN SULFIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PH; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; CONGENITAL HEART MALFORMATION; METABOLISM; NEWBORN; PRESCHOOL CHILD;

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 84896831980     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132694     Document Type: Article

References (35)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-S54.
2. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
3. Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H. Biomarkers in pulmonary hypertension: what do we know? Chest 2013; 144: 274-283.
4. Silva MJ, Martins SR, Calisto C, Goncalves S, Almeida AG, de Sousa JC, et al. An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: emerging role of CT-proET-1. J Heart Lung Transplant 2013; 13: S1053-S2498.
5. Vandiver M, Snyder SH. Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med (Berl) 2012; 90: 255-263.
6. Bearden SE, Beard RJ, Pfau JC. Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress. Am J Physiol Heart Circ Physiol 2010; 299: H1568-H1576.
7. Kuwahara K, Nanri A, Pham NM, Kurotani K, Kume A, Sato M, et al. Serum vitamin B6, folate, and homocysteine concentrations and oxidative DNA damage in Japanese men and women. Nutrition 2013; 29: 1219-1223.
8. Liu DS, Gao W, Liang ES, Wang SL, Lin WW, Zhang WD, et al. Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction. Eur J Pharmacol 2013; 714: 163-169.
9. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103: 2376-2381.
10. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005; 81: 1213S-1217S.
11. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimusand paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
12. Moens AL, Vrints CJ, Claeys MJ, Timmermans JP, Champion HC, Kass DA. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008; 294: H1971-H1977.
13. Moens AL, Claeys MJ, Wuyts FL, Goovaerts I, Van Hertbruggen E, Wendelen LC, et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2007; 99: 476-481.
14. Lange H, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004; 350: 2673-2681.
15. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase Circ Res 2000; 86: 1129-1134.
16. Hjemdahl P. Smoking, nicotine and thrombotic risk-a role for platelet dependent thrombin generation? Eur Heart J 2001; 22: 16-18.
17. Kuch B, Bobak M, Fobker M, Junker R, von Eckardstein A, Marmot M, et al. Associations between homocysteine and coagulation factors-a cross-sectional study in two populations of central Europe. Thromb Res 2001; 103: 265-273.
18. James WP, Garrow JS. Human nutrition and dietetics, 9th ed. edited by Garrow JS, James WP; editorial assistant, Ann Ralph. ed. Edinburgh: Churchill Livingstone; 1993: 271-280.
19. Bailey LB. Folate in health and disease, 2nd ed. Boca Raton: Taylor & Francis; 2010: 381-408.
20. Hughes CF, Ward M, Hoey L, McNulty H. Vitamin B12 and ageing: current issues and interaction with folate. Ann Clin Biochem 2013; 50: 315-329.
21. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 2005; 16: 467-478.
22. Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 2007; 21: 113-130.
23. Nexo E, Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011; 94: 359S-365S.
24. Ang L, Thani KB, Ilapakurti M, Lee MS, Palakodeti V, Mahmud E. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. J Am Coll Cardiol 2013; 61: 23-34.
25. Beard RJ, Bearden SE. Vascular complications of cystathionine beta-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011; 300: H13-H26.
26. Zoccolella S, Dell'Aquila C, Specchio LM, Logroscino G, Lamberti P. Elevated homocysteine levels in Parkinson's Disease: is there anything besides L-dopa treatment? Curr Med Chem 2010; 17: 213-221.
27. Kocer B, Engur S, Ak F, Yilmaz M. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J Clin Neurosci 2009; 16: 399-403.
28. Marti-Carvajal AJ, Sola I, Lathyris D, Karakitsiou DE, Simancas-Racines D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2013; 1: D6612.
29. Pan LL, Liu XH, Gong QH, Yang HB, Zhu YZ. Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal 2012; 17: 106-118.
30. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 293: H2093-H2100.
31. Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, et al. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol 2007; 292: H1953-H1960.
32. Li XH, Du JB, Bu DF, Tang XY, Tang CS. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Acta Pharmacol Sin 2006; 27: 971-980.
33. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, et al. H2S signals through protein S-sulfhydration. Sci Signal 2009; 2: ra72.
34. Kohli U, Arora S, Kabra M, Ramakrishnan L, Gulati S, Pandey RM. Prevalence of MTHFR C677T polymorphism in north Indian mothers having babies with Trisomy 21 Down syndrome. Downs Syndr Res Pract 2008; 12: 133-137.
35. Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl 2007; 9: 57-62